Add-on Aripiprazole for Atypical Antipsychotic-induced, Clinically Significant Hyperprolactinemia

BACKGROUND: Antipsychotic treatment-induced hyperprolactinemia is a highly distressing and disabling side effect for patients. The use of add-on aripiprazole has been identified as a possible treatment strategy in this situation. However, data on prolactin changes with add-on aripiprazole in a real-...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Indian J Psychol Med
Autors principals: Raveendranthan, Dhanya, Rao, Naren P., Rao, Mukund G., Mangot, Ajish G., Varambally, Shivaram, Kesavan, Muralidharan, Venkatasubramanian, Ganesan, Gangadhar, Bangalore N.
Format: Artigo
Idioma:Inglês
Publicat: Medknow Publications & Media Pvt Ltd 2018
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5795677/
https://ncbi.nlm.nih.gov/pubmed/29403128
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/IJPSYM.IJPSYM_147_17
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars